BACKGROUND: The purpose of this study was to assess the effect of human immunodeficiency virus (HIV) infection on postoperative survival among non-small cell lung cancer (NSCLC) patients. METHODS: A retrospective cohort study compared 22 HIV-infected lung cancer patients to 2,430 lung cancer patients with HIV-unspecified status who underwent resection at Johns Hopkins Hospital from 1985 to 2009. Subcohort comparative analyses were performed using individual matching methods. RESULTS: Thirty-day mortality rates did not differ between HIV-infected and HIV-unspecified patients. Survival rates for HIV-infected lung cancer patients were significantly shorter than for HIV-unspecified patients (median, 26 versus 48 months; p=0.001). After adjustment, the relative hazard of mortality among HIV-infected NSCLC patients was more than threefold that of HIV-unspecified patients (adjusted hazard ratio, 3.08; 95% confidence interval: 1.85 to 5.13). When additional surgical characteristics were modeled in a matched subcohort, the association remained statistically significant (adjusted hazard ratio, 2.31; 95% confidence interval: 1.11 to 4.81). Moreover, HIV-infected lung cancer patients with CD4 counts less than 200 cells/mm3 had shortened median survival compared with patients whose CD4 counts were 200 cells/mm3 or greater (8 versus 40 months; p=0.031). Postoperative pulmonary and infectious complications were also elevated in the HIV-infected group (p=0.001 and p<0.001, respectively). After surgery, median time to cancer progression was shorter among HIV-infected patients (20.4 months) versus HIV-unspecified patients (p=0.061). CONCLUSIONS: The HIV-infected NSCLC patients have more postoperative complications, rapid progression to disease recurrence, and poorer postoperative survival. Optimizing immune status before surgery and careful patient selection based on diffusion capacity of lung for carbon monoxide may improve patient outcomes.
BACKGROUND: The purpose of this study was to assess the effect of human immunodeficiency virus (HIV) infection on postoperative survival among non-small cell lung cancer (NSCLC) patients. METHODS: A retrospective cohort study compared 22 HIV-infected lung cancerpatients to 2,430 lung cancerpatients with HIV-unspecified status who underwent resection at Johns Hopkins Hospital from 1985 to 2009. Subcohort comparative analyses were performed using individual matching methods. RESULTS: Thirty-day mortality rates did not differ between HIV-infected and HIV-unspecifiedpatients. Survival rates for HIV-infected lung cancerpatients were significantly shorter than for HIV-unspecifiedpatients (median, 26 versus 48 months; p=0.001). After adjustment, the relative hazard of mortality among HIV-infected NSCLCpatients was more than threefold that of HIV-unspecifiedpatients (adjusted hazard ratio, 3.08; 95% confidence interval: 1.85 to 5.13). When additional surgical characteristics were modeled in a matched subcohort, the association remained statistically significant (adjusted hazard ratio, 2.31; 95% confidence interval: 1.11 to 4.81). Moreover, HIV-infected lung cancerpatients with CD4 counts less than 200 cells/mm3 had shortened median survival compared with patients whose CD4 counts were 200 cells/mm3 or greater (8 versus 40 months; p=0.031). Postoperative pulmonary and infectious complications were also elevated in the HIV-infected group (p=0.001 and p<0.001, respectively). After surgery, median time to cancer progression was shorter among HIV-infectedpatients (20.4 months) versus HIV-unspecifiedpatients (p=0.061). CONCLUSIONS: The HIV-infected NSCLCpatients have more postoperative complications, rapid progression to disease recurrence, and poorer postoperative survival. Optimizing immune status before surgery and careful patient selection based on diffusion capacity of lung for carbon monoxide may improve patient outcomes.
Authors: I I Wistuba; C Behrens; S Milchgrub; A K Virmani; J Jagirdar; B Thomas; H L Ioachim; L A Litzky; E M Brambilla; J D Minna; A F Gazdar Journal: JAMA Date: 1998-05-20 Impact factor: 56.272
Authors: Malcolm V Brock; Craig M Hooker; Eric A Engels; Richard D Moore; Maura L Gillison; Anthony J Alberg; Jeanne C Keruly; Stephen C Yang; Richard F Heitmiller; Stephen B Baylin; James G Herman; Julie R Brahmer Journal: J Acquir Immune Defic Syndr Date: 2006-09 Impact factor: 3.731
Authors: Anil K Chaturvedi; Ruth M Pfeiffer; Leonard Chang; James J Goedert; Robert J Biggar; Eric A Engels Journal: AIDS Date: 2007-01-11 Impact factor: 4.177
Authors: Mark Bower; Tom Powles; Mark Nelson; Pallav Shah; Sarah Cox; Sundhiya Mandelia; Brian Gazzard Journal: AIDS Date: 2003-02-14 Impact factor: 4.177
Authors: Keith M Sigel; Kimberly Stone; Juan P Wisnivesky; Lesley S Park; Chung Yin Kong; Michael J Silverberg; Sheldon Brown; Matthew Goetz; Maria C Rodriguez-Barradas; Cynthia Gibert; Fatma Shebl; Roger Bedimo; Roxanne Wadia; Joseph King; Kristina Crothers Journal: AIDS Date: 2019-07-01 Impact factor: 4.177
Authors: Keith Sigel; Juan Wisnivesky; Shahida Shahrir; Sheldon T Brown; Amy Justice; Joon Kim; Maria C Rodriguez-Barradas; Kathleen M Akgün; David Rimland; Guy W Soo Hoo; Kristina Crothers Journal: AIDS Date: 2014-04-24 Impact factor: 4.177
Authors: Joseph T King; Melissa F Perkal; Ronnie A Rosenthal; Adam J Gordon; Stephen Crystal; Maria C Rodriguez-Barradas; Adeel A Butt; Cynthia L Gibert; David Rimland; Michael S Simberkoff; Amy C Justice Journal: JAMA Surg Date: 2015-04 Impact factor: 14.766
Authors: Amber Chi; Bryan E Adams; Joanna Sesti; Subroto Paul; Amber L Turner; David August; Darren Carpizo; Timothy Kennedy; Miral Grandhi; H Richard Alexander; Steven K Libutti; Stuart Geffner; Russell C Langan Journal: World J Surg Date: 2019-12 Impact factor: 3.352
Authors: Alicia Hulbert; Craig M Hooker; Jeanne C Keruly; Travis Brown; Karen Horton; Eliott Fishman; Kristen Rodgers; Beverly Lee; Celis Sam; Salina Tsai; Elizabeth Weihe; Genevieve Pridham; Brad Drummond; Christian Merlo; Maria Geronimo; Michelle Porter; Solange Cox; Dan Li; Marian Harline; Mario Teran; John Wrangle; Beatrice Mudge; Gregory Taylor; Gregory D Kirk; James G Herman; Richard D Moore; Robert H Brown; Malcolm V Brock Journal: J Thorac Oncol Date: 2014-06 Impact factor: 15.609